Malchione M.D.; Torres L.M.; Hartley D.M.; Koch M.; Goodman J.L.
(2019)
Carbapenem-resistant Enterobacteriaceae infections have spread globally, leaving polymyxins, including colistin, as ‘last-resort treatments’. Emerging colistin resistance raises the spectre of untreatable infections. Despite ...